Tonix Pharmaceuticals Holding EBITDA 2009-2019 | TNXP

Tonix Pharmaceuticals Holding ebitda from 2009 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Tonix Pharmaceuticals Holding Annual EBITDA
(Millions of US $)
2018 $-26
2017 $-21
2016 $-39
2015 $-48
2014 $-28
2013 $-11
2012 $-6
2011 $-3
2010 $-2
2009 $-0
2008 $-0
2007 $-0
Tonix Pharmaceuticals Holding Quarterly EBITDA
(Millions of US $)
Q1 2019 $-6
Q4 2018 $-8
Q3 2018 $-6
Q2 2018 $-6
Q1 2018 $-7
Q4 2017 $-6
Q3 2017 $-6
Q2 2017 $-5
Q1 2017 $-5
Q4 2016 $-7
Q3 2016 $-8
Q2 2016 $-10
Q1 2016 $-14
Q4 2015 $-13
Q3 2015 $-13
Q2 2015 $-12
Q1 2015 $-10
Q4 2014 $-9
Q3 2014 $-7
Q2 2014 $-6
Q1 2014 $-5
Q4 2013 $-4
Q3 2013 $-3
Q2 2013 $-2
Q1 2013 $-2
Q4 2012 $-2
Q3 2012 $-2
Q2 2012 $-2
Q1 2012 $-1
Q4 2011 $-1
Q3 2011 $-1
Q2 2011 $-0
Q1 2011 $-1
Q4 2010 $-2
Q3 2010 $-0
Q2 2010 $-0
Q1 2010 $-0
Q4 2009 $-0
Q3 2009 $-0
Q2 2009 $-0
Q1 2009 $-0
Q4 2008 $-0
Q3 2008 $-0
Q2 2008 $-0
Q1 2008 $-0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.000B
Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.610B 34.89
Astellas Pharma (ALPMY) Japan $28.433B 13.94
Takeda Pharmaceutical (TAK) Japan $27.154B 7.97
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.807B 27.18
Grifols, S.A (GRFS) Spain $15.209B 19.24
Merck (MKGAF) Germany $13.448B 18.35
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.649B 21.09
Sage Therapeutics (SAGE) United States $9.439B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Catalent (CTLT) United States $7.912B 31.75
Neurocrine Biosciences (NBIX) United States $7.824B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.738B 10.61
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.573B 9.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.805B 16.89
Evotec AG (EVTCY) Germany $4.267B 45.80
Tilray (TLRY) Canada $4.238B 0.00
FibroGen (FGEN) United States $3.983B 0.00
United Therapeutics (UTHR) United States $3.300B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.220B 11.56
Arrowhead Pharmaceuticals (ARWR) United States $2.766B 416.71
PTC Therapeutics (PTCT) United States $2.514B 0.00
Xencor (XNCR) United States $2.513B 68.60
Zogenix (ZGNX) United States $2.035B 0.00
Portola Pharmaceuticals (PTLA) United States $1.814B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.658B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.647B 79.76
Enanta Pharmaceuticals (ENTA) United States $1.613B 22.04
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.462B 12.71
Heron Therapeutics (HRTX) United States $1.461B 0.00
Corcept Therapeutics (CORT) United States $1.263B 18.03
ArQule (ARQL) United States $1.158B 0.00
Aerie Pharmaceuticals (AERI) United States $1.062B 0.00
Radius Health (RDUS) United States $1.035B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.986B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.879B 0.00
Endo (ENDP) Ireland $0.740B 1.19
Concordia (CXRXF) Canada $0.716B 0.00
Aptorum Group (APM) China $0.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.577B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.574B 0.00
Organogenesis Holdings (ORGO) United States $0.562B 0.00
TherapeuticsMD (TXMD) United States $0.543B 0.00
Karyopharm Therapeutics (KPTI) United States $0.505B 0.00
GlycoMimetics (GLYC) United States $0.482B 0.00
ChemoCentryx (CCXI) United States $0.474B 0.00
Translate Bio (TBIO) United States $0.472B 0.00
Akebia Therapeutics (AKBA) United States $0.457B 0.00
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Dermira (DERM) United States $0.450B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.444B 22.38
Siga Technologies (SIGA) United States $0.440B 1.04
Catalyst Pharmaceuticals (CPRX) United States $0.417B 0.00
CV Sciences (CVSI) United States $0.413B 0.00
Flexion Therapeutics (FLXN) United States $0.412B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.403B 0.00
CannTrust Holdings (CTST) Canada $0.391B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.390B 0.00
Indivior (INVVY) United States $0.386B 1.39
BioCryst Pharmaceuticals (BCRX) United States $0.374B 0.00
Innate Pharma SA (IPHYF) France $0.364B 0.00
Harpoon Therapeutics (HARP) United States $0.348B 0.00
ImmunoGen (IMGN) United States $0.348B 0.00
Collegium Pharmaceutical (COLL) United States $0.346B 0.00
Xeris Pharmaceuticals (XERS) United States $0.331B 0.00
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.288B 0.00
Molecular Templates (MTEM) United States $0.272B 0.00
Concert Pharmaceuticals (CNCE) United States $0.256B 0.00
OptiNose (OPTN) United States $0.250B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.236B 0.00
Lannett Co Inc (LCI) United States $0.235B 2.28
Recro Pharma (REPH) United States $0.220B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.215B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.193B 0.00
Redhill Biopharma (RDHL) Israel $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 56.63
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Calithera Biosciences (CALA) United States $0.162B 0.00
Ardelyx (ARDX) United States $0.157B 0.00
IMV INC (IMV) Canada $0.152B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.151B 0.00
Jounce Therapeutics (JNCE) United States $0.136B 0.00
Majesco Entertainment (PTE) United States $0.132B 0.00
MEI Pharma (MEIP) United States $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.131B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Generex Biotechnology (GNBT) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
MediWound (MDWD) Israel $0.101B 0.00
RENEURON GP (RNUGF) United Kingdom $0.100B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Infinity Pharmaceuticals (INFI) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.089B 0.00
Champions Oncology (CSBR) United States $0.089B 768.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Capnia (SLNO) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 63.00
Nivalis Therapeutics (ALPN) United States $0.088B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.080B 0.00
Natural Alternatives (NAII) United States $0.079B 7.90
Otonomy (OTIC) United States $0.077B 0.00
China SXT Pharmaceuticals (SXTC) China $0.075B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.074B 0.00
Novan (NOVN) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bio-Path Holdings (BPTH) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Opexa Therapeutics (ACER) United States $0.031B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.46
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00